Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The treatment of Clostridioides difficile infection (CDI) (initial) is challenging partly due to the emergence of antibiotic-resistant strains and the lack of efficient vaccines, which often leads to individuals experiencing recurrent Clostridioides difficile infection (CDI). Consequently, there is an urgent need for the development of new therapeutic approaches.
The current treatment guidelines in America and Europe suggest using Vancomycin or [Fidaxomicin](brain://VcWrUjiIKEu5NRN_W_C-Og/FidaxomicinClostridioidesDifficileInfectionC…